BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

337 related articles for article (PubMed ID: 34346447)

  • 1. Identification of potent anticancer copper(ii) complexes containing tripodal bis[2-ethyl-di(3,5-dialkyl-1H-pyrazol-1-yl)]amine moiety.
    Massoud SS; Louka FR; Dial MT; Malek AJ; Fischer RC; Mautner FA; Vančo J; Malina T; Dvořák Z; Trávníček Z
    Dalton Trans; 2021 Sep; 50(33):11521-11534. PubMed ID: 34346447
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Copper(II) complexes based on tripodal pyrazolyl amines: Synthesis, structure, magnetic properties and anticancer activity.
    Massoud SS; Louka FR; Ducharme GT; Fischer RC; Mautner FA; Vančo J; Herchel R; Dvořák Z; Trávníček Z
    J Inorg Biochem; 2018 Mar; 180():39-46. PubMed ID: 29232637
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nitroimidazole and glucosamine conjugated heteroscorpionate ligands and related copper(II) complexes. Syntheses, biological activity and XAS studies.
    Pellei M; Papini G; Trasatti A; Giorgetti M; Tonelli D; Minicucci M; Marzano C; Gandin V; Aquilanti G; Dolmella A; Santini C
    Dalton Trans; 2011 Oct; 40(38):9877-88. PubMed ID: 21709917
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Five-Coordinated Geometries from Molecular Structures to Solutions in Copper(II) Complexes Generated from Polydentate-
    Mautner FA; Fischer RC; Torvisco A; Henary MM; Louka FR; Massoud SS; Salem NMH
    Molecules; 2020 Jul; 25(15):. PubMed ID: 32722383
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low symmetry pyrazole-based tripodal tetraamine ligands: metal complexes and ligand decomposition reactions.
    Cubanski JR; Cameron SA; Crowley JD; Blackman AG
    Dalton Trans; 2013 Feb; 42(6):2174-85. PubMed ID: 23192397
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Syntheses and biological studies of nitroimidazole conjugated heteroscorpionate ligands and related Cu(I) and Cu(II) complexes.
    Pellei M; Gandin V; Cimarelli C; Quaglia W; Mosca N; Bagnarelli L; Marzano C; Santini C
    J Inorg Biochem; 2018 Oct; 187():33-40. PubMed ID: 30053534
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Copper(II) Complexes Containing Natural Flavonoid Pomiferin Show Considerable In Vitro Cytotoxicity and Anti-inflammatory Effects.
    Vančo J; Trávníček Z; Hošek J; Malina T; Dvořák Z
    Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299247
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Syntheses and Biological Studies of Cu(II) Complexes Bearing Bis(pyrazol-1-yl)- and Bis(triazol-1-yl)-acetato Heteroscorpionate Ligands.
    Pellei M; Gandin V; Marchiò L; Marzano C; Bagnarelli L; Santini C
    Molecules; 2019 May; 24(9):. PubMed ID: 31067640
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In situ synthesis of mononuclear copper(II) complexes of the new tridentate ligand bis[(3,5-dimethyl-1H-pyrazol-1-yl)methyl]amine.
    Yu F
    Acta Crystallogr C; 2011 Oct; 67(Pt 10):m331-4. PubMed ID: 21979969
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DNA binding, cleavage and cytotoxicity studies of three mononuclear Cu(II) chloro-complexes containing N-S donor Schiff base ligands.
    Parsekar SU; Fernandes J; Banerjee A; Chouhan OP; Biswas S; Singh M; Mishra DP; Kumar M
    J Biol Inorg Chem; 2018 Dec; 23(8):1331-1349. PubMed ID: 30302601
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Solution equilibrium, structural and cytotoxicity studies on Ru(η
    Dömötör O; Kiss MA; Gál GT; May NV; Spengler G; Nové M; Gašparović AČ; Frank É; Enyedy ÉA
    J Inorg Biochem; 2020 Jan; 202():110883. PubMed ID: 31689626
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exploring the Antitumor Potential of Copper Complexes Based on Ester Derivatives of Bis(pyrazol-1-yl)acetate Ligands.
    Pellei M; Santini C; Bagnarelli L; Battocchio C; Iucci G; Venditti I; Meneghini C; Amatori S; Sgarbossa P; Marzano C; De Franco M; Gandin V
    Int J Mol Sci; 2022 Aug; 23(16):. PubMed ID: 36012662
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dinuclear doubly bridged phenoxido copper(II) complexes as efficient anticancer agents.
    Massoud SS; Louka FR; Salem NMH; Fischer RC; Torvisco A; Mautner FA; Vančo J; Belza J; Dvořák Z; Trávníček Z
    Eur J Med Chem; 2023 Jan; 246():114992. PubMed ID: 36525695
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dinuclear copper(II) complexes with a bridging bis(chalcone) ligand reveal considerable in vitro cytotoxicity on human cancer cells and enhanced selectivity.
    Trávníček Z; Vančo J; Belza J; Zoppellaro G; Dvořák Z
    J Inorg Biochem; 2024 Mar; 252():112481. PubMed ID: 38215536
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pyrazole appended quinoline-BODIPY based arene ruthenium complexes: their anticancer activity and potential applications in cellular imaging.
    Paitandi RP; Sharma V; Singh VD; Dwivedi BK; Mobin SM; Pandey DS
    Dalton Trans; 2018 Dec; 47(48):17500-17514. PubMed ID: 30507985
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and Cytotoxic Activity Evaluation of New Cu(I) Complexes of Bis(pyrazol-1-yl) Acetate Ligands Functionalized with an NMDA Receptor Antagonist.
    Pellei M; Bagnarelli L; Luciani L; Del Bello F; Giorgioni G; Piergentili A; Quaglia W; De Franco M; Gandin V; Marzano C; Santini C
    Int J Mol Sci; 2020 Apr; 21(7):. PubMed ID: 32283777
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Syntheses, Crystal Structures, and Antitumor Activities of Copper(II) and Nickel(II) Complexes with 2-((2-(Pyridin-2-yl)hydrazono)methyl)quinolin-8-ol.
    Yang QY; Cao QQ; Qin QP; Deng CX; Liang H; Chen ZF
    Int J Mol Sci; 2018 Jun; 19(7):. PubMed ID: 29949884
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytotoxic Ruthenium(II) Complexes of Pyrazolylbenzimidazole Ligands That Inhibit VEGFR2 Phosphorylation.
    Chakraborty A; Roy S; Chakraborty MP; Roy SS; Purkait K; Koley TS; Das R; Acharya M; Mukherjee A
    Inorg Chem; 2021 Dec; 60(23):18379-18394. PubMed ID: 34780170
    [TBL] [Abstract][Full Text] [Related]  

  • 19. May iron(III) complexes containing phenanthroline derivatives as ligands be prospective anticancer agents?
    Matos CP; Adiguzel Z; Yildizhan Y; Cevatemre B; Onder TB; Cevik O; Nunes P; Ferreira LP; Carvalho MD; Campos DL; Pavan FR; Pessoa JC; Garcia MH; Tomaz AI; Correia I; Acilan C
    Eur J Med Chem; 2019 Aug; 176():492-512. PubMed ID: 31132480
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis, characterisation and biological activities of [(p-cym)RuX(pz4lut)]n+ and [{(p-cym)RuX}2(μ-pz4lut)]n+ (X = Cl, H2O and pz4lut = α,α,α',α'-tetra(pyrazol-1-yl)-2,6-lutidine).
    Tripathy SK; Surada RK; Manne RK; Mobin SM; Santra MK; Patra S
    Dalton Trans; 2013 Oct; 42(39):14081-91. PubMed ID: 23938874
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.